Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Rimm

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 5, 1997
Localization and quantitation of expression of the cell motility-related protein thymosin beta15 in human breast tissueJ S Gold, L Bao, R A Ghoussoub, et al.
Cancer|February 25, 1997
Comparison of the costs of fine-needle aspiration and open surgical biopsy as methods for obtaining a pathologic diagnosisD L Rimm, J F Stastny, E B Rimm, et al.
Oral Oncology|May 5, 2019
Corrigendum to "Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma" [Oral Oncol. 86 (2018) 278-287]D J Hartman, F S Ahmed, R L Ferris, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 12, 1995
Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complexD L Rimm, E R Koslov, P Kebriaei, et al.
American Journal of Epidemiology|July 1, 1989
Obesity and heredity in the etiology of non-insulin-dependent diabetes mellitus in 32,662 adult white womenR D Morris, D L Rimm, A J Hartz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2009
Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancerY Nadler, A M González, R L Camp, et al.
International Journal of Cancer|July 31, 2001
Novel inactivating mutations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastasesT Chen, W Yan, R G Wells, et al.
The American Journal of Pathology|March 10, 2001
Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosisG Garcia-Rostan, R L Camp, A Herrero, et al.
Cancer Journal (Sudbury, Mass.)|March 28, 2001
Tissue microarray: a new technology for amplification of tissue resourcesD L Rimm, R L Camp, L A Charette, et al.
Cancer Research|April 23, 1999
Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinomaG Garcia-Rostan, G Tallini, A Herrero, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 5, 1997
Localization and quantitation of expression of the cell motility-related protein thymosin beta15 in human breast tissueJ S Gold, L Bao, R A Ghoussoub, et al.
Cancer|February 25, 1997
Comparison of the costs of fine-needle aspiration and open surgical biopsy as methods for obtaining a pathologic diagnosisD L Rimm, J F Stastny, E B Rimm, et al.
Oral Oncology|May 5, 2019
Corrigendum to "Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma" [Oral Oncol. 86 (2018) 278-287]D J Hartman, F S Ahmed, R L Ferris, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 12, 1995
Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complexD L Rimm, E R Koslov, P Kebriaei, et al.
American Journal of Epidemiology|July 1, 1989
Obesity and heredity in the etiology of non-insulin-dependent diabetes mellitus in 32,662 adult white womenR D Morris, D L Rimm, A J Hartz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2009
Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancerY Nadler, A M González, R L Camp, et al.
International Journal of Cancer|July 31, 2001
Novel inactivating mutations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastasesT Chen, W Yan, R G Wells, et al.
The American Journal of Pathology|March 10, 2001
Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosisG Garcia-Rostan, R L Camp, A Herrero, et al.
Cancer Journal (Sudbury, Mass.)|March 28, 2001
Tissue microarray: a new technology for amplification of tissue resourcesD L Rimm, R L Camp, L A Charette, et al.
Cancer Research|April 23, 1999
Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinomaG Garcia-Rostan, G Tallini, A Herrero, et al.
Pageof 8